Principal Investigator
Teresa S.M. Tsang, MD
Co-Investigators
Purang Abolmaesumi, PhD
Ali Bashashati-Saghezchi, PhD
Laura Arbour, PhD
Steven Jones, PhD
Anna Lehman, MD
Marco A. Marra, PhD
Variants Evaluated for Cardiometabolic and Pharmacogenomic Tiers Of Risk. VECTOR will develop a virtual panel of approximately 150 cardiometabolic and pharmacogenomic genes and link genomic findings with clinical, imaging, pharmacy and health-system data to evaluate their value for predicting cardiovascular outcomes and medication response.
Co-applicant Team
Dr. Teresa Tsang
Dr. Purang Abolmaesumi
Dr. Gabrielle Legault
Dr. Gillian Hanley
Dr. Anna Lehman
Dr. Jacqueline Saw
Dr. Tara Sedlak
Dr. Anna Meredith
Dr. Spencer Anderson
Isabelle Korchinski
The SMART Women (Strategic Multi-Omics, Artificial Intelligence, and Advanced Imaging for Resilience and Healthy Trajectories in Women) initiative brings together provincial and national expertise to advance precision health for women across the life course through the integration of genomics, artificial intelligence, advanced cardiovascular imaging, biomarkers, and longitudinal health outcomes.
MOSAIC improves heart care by bringing services closer to home, using resources wisely, and studying how the environment affects heart health.
In 2023, the Canadian Institute of Health Research (CIHR), funded the development of a Pan-Canadian Genome Library (PCGL) aimed at the management and sharing of human genomic data. Read more
A new research effort at UBC is reimagining how heart disease is detected and treated across the province, and it starts with meeting patients closer to home. Read more
Just what the doctor ordered
Cardiologist Teresa Tsang is using AI to advance and democratize cardiac imaging in BC. Read more
Artificial intelligence (AI) is transforming industries worldwide, and health care is no exception. Vancouver Coastal Health (VCH) is harnessing the power of AI to revolutionize health care delivery, Read more
The VGH-UBC AI Echo Core Lab offers third-party interpretation of echocardiographic studies for clinical trials and serves as consultants or collaborators for studies worldwide. Read more
A Vancouver-based research team is using artificial intelligence to change how doctors detect and diagnose heart failure—a condition experts say is becoming increasingly common across Canada. Read more
